Search for: "RISING PHARMACEUTICALS, INC."
Results 161 - 180
of 462
Sort by Relevance
|
Sort by Date
26 May 2015, 7:42 am
Claims such as in Mills, which are at loggerheads with FDA criteria for drug development, are precisely those with the most potential for making pharmaceutical manufacturers into “sitting ducks” for litigation, in this instance litigation based on extraneous genetic factors.It may well be that the coming (and to some extent existing) revolution in genetically individualized medical therapy will require changes in how drugs are evaluated, labeled, etc., but this is a… [read post]
25 May 2015, 1:28 am
Similarly in Conor Medsystems Inc v Angiotech Pharmaceuticals Inc. [2008] UKHL 49 the House of Lords tried to change inventive step case law in the UK to be more in line with EPO thinking.The correcting guidance of oversightThe US Committee on Oversight and Government Reform (here) keeps an eye on the activities of the US government. [read post]
14 May 2015, 4:00 am
In Eli Lilly Canada Inc. v. [read post]
25 Apr 2015, 11:03 am
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
24 Apr 2015, 12:29 pm
Listen to the Show Controls Limit Workers Comp Drug Price Rise To 1.9%: Express Scripts Utilization controls for workers compensation pharmaceutical claims have limited opioid painkiller and compounded drug usage and helped contain escalating costs for those drug categories, pharmacy benefit manager Express Scripts Inc. said. [read post]
26 Mar 2015, 7:55 am
When the curtain rose for oral argument in Omnicare, Inc. v. [read post]
25 Mar 2015, 12:25 am
In a March 24, 2015 opinion in Omnicare, Inc. v. [read post]
11 Mar 2015, 9:40 am
Akamai Technologies, Inc., 134 S.Ct. 2111 (2014) (divided infringement) Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
5 Mar 2015, 5:52 am
Mylan Pharmaceutical, Inc., ___ F. [read post]
5 Feb 2015, 1:44 pm
Aventis Pasteur, Inc., 270 F. [read post]
4 Feb 2015, 1:52 pm
., Inc. v. [read post]
22 Jan 2015, 9:56 pm
The petitioners, Teva Pharmaceuticals (along with related firms), own the relevant patent. [read post]
6 Jan 2015, 6:15 am
In November, an Iowa woman and her husband filed suit against the Japanese pharmaceutical company Daiichi Sankyo Inc., claiming that after being prescribed Azor in January 2011, she continued to take the hypertension medication as directed for some time. [read post]
17 Dec 2014, 12:38 pm
” In Matrixx Initiatives Inc. v. [read post]
8 Dec 2014, 12:42 pm
” MedImmune, Inc. [read post]
16 Nov 2014, 4:00 am
Pharmaceuticals: Delayed Market EntryApotex Inc. v. [read post]
6 Nov 2014, 5:00 am
The reasoning is not applicable to a scenario outside of the prescription pharmaceutical context and the rise of direct-to-consumer advertising. [read post]
5 Nov 2014, 6:30 am
Cost of WC claims rises dramatically when IWs hire attorneys. [read post]
2 Nov 2014, 11:14 am
Securities fraud is back in the Supreme Court in Omnicare, Inc. v. [read post]
29 Oct 2014, 3:25 am
As the grant of patent gives rise to a private right, the infringement does not engage the public interest. [read post]
